Literature DB >> 24497298

Placental mosaicism for Trisomy 13: a challenge in providing the cell-free fetal DNA testing.

Xiang-Yin Liu1, Hong-Guo Zhang, Rui-Xue Wang, Shuang Chen, Xiao-Wei Yu, Rui-Zhi Liu.   

Abstract

PURPOSE: We investigated the disagreement between the positive cell-free fetal DNA test for trisomy 13 and the standard cytogenetic diagnosis of one case.
METHODS: Cell-free fetal DNA testing was performed by massively parallel sequencing. We used conventional cytogenetic analysis to confirm the commercial cell-free fetal DNA testing. Additionally, postnatal fluorescent in situ hybridization (FISH) testing was performed on placental tissues.
RESULTS: The cell-free fetal DNA testing result was positive for trisomy 13. G-banded analysis of amniotic fluid was normal, 46, XY. FISH testing of tissues from four quadrants of the placenta demonstrated mosaicism for trisomy 13.
CONCLUSIONS: A positive cell-free fetal DNA testing result may not be representative of the fetal karyotype because of placental mosaicism. Cytogenetic analysis should be performed when abnormal cell-free fetal DNA test results are obtained.

Entities:  

Mesh:

Year:  2014        PMID: 24497298      PMCID: PMC4016375          DOI: 10.1007/s10815-014-0182-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  46 in total

1.  Use of interphase fluorescence in situ hybridization in third trimester fetuses with anomalies and growth retardation.

Authors:  A Aviram-Goldring; M Daniely; H Dorf; R Chaki; B Goldman; G Barkai
Journal:  Am J Med Genet       Date:  1999-11-26

2.  Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.

Authors:  M Alberry; D Maddocks; M Jones; M Abdel Hadi; S Abdel-Fattah; N Avent; P W Soothill
Journal:  Prenat Diagn       Date:  2007-05       Impact factor: 3.050

3.  Circulating nucleic acids in plasma and serum. Recent developments.

Authors:  Peter B Gahan; R Swaminathan
Journal:  Ann N Y Acad Sci       Date:  2008-08       Impact factor: 5.691

4.  Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?

Authors:  Michael T Mennuti; Athena M Cherry; Jennifer J D Morrissette; Lorraine Dugoff
Journal:  Am J Obstet Gynecol       Date:  2013-03-22       Impact factor: 8.661

5.  Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.

Authors:  Tze Kin Lau; Fu Man Jiang; Robert J Stevenson; Tsz Kin Lo; Lin Wai Chan; Mei Ki Chan; Pui Shan Salome Lo; Wei Wang; Hong-Yun Zhang; Fang Chen; Kwong Wai Choy
Journal:  Prenat Diagn       Date:  2013-04-02       Impact factor: 3.050

6.  Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y.

Authors:  K H Nicolaides; A Syngelaki; M Gil; V Atanasova; D Markova
Journal:  Prenat Diagn       Date:  2013-04-24       Impact factor: 3.050

7.  Investigation of confined placental mosaicism by CGH in IVF and ICSI pregnancies.

Authors:  E Chan Wong; C Hatakeyama; A Minor; S Ma
Journal:  Placenta       Date:  2012-01-10       Impact factor: 3.481

8.  Confined placental mosaicism and pregnancy outcome: a distinction needs to be made between types 2 and 3.

Authors:  Jérôme Toutain; Cécile Labeau-Gaüzere; Thomas Barnetche; Jacques Horovitz; Robert Saura
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

9.  Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.

Authors:  Shilpa Chetty; Matthew J Garabedian; Mary E Norton
Journal:  Prenat Diagn       Date:  2013-06       Impact factor: 3.050

10.  Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy.

Authors:  Andrew B Sparks; Eric T Wang; Craig A Struble; Wade Barrett; Renee Stokowski; Celeste McBride; Jacob Zahn; Kevin Lee; Naiping Shen; Jigna Doshi; Michel Sun; Jill Garrison; Jay Sandler; Desiree Hollemon; Patrick Pattee; Aoy Tomita-Mitchell; Michael Mitchell; John Stuelpnagel; Ken Song; Arnold Oliphant
Journal:  Prenat Diagn       Date:  2012-01-06       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.